Home
Conditions
Neoplasms, Ductal, Lobular, and Medullary

Clinical trial condition

Neoplasms, Ductal, Lobular, and Medullary

Explore clinical trials studying Neoplasms, Ductal, Lobular, and Medullary. Study availability and eligibility vary by location and protocol.

487 public trials 100 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Ductal, Lobular, and Medullary trial results

Completed

Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer

NCT00002873

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +11 more
Locations: Veterans Affairs Medical Center - Birmingham Birmingham, Alabama, United States

University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States

Huntsville Hospital System Huntsville, Alabama, United States

Urology Associates - Mobile AL Mobile, Alabama, United States

View all 232 locations

View Trial Details

Completed

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

NCT00002608

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +71 more
Locations: Ottawa Regional Cancer Centre at Ottawa Hospital - General Campus Ottawa, Ontario, Canada

View Trial Details

Completed

Radiation Therapy Planning Techniques in Reducing Damage to Normal Tissue in Women Undergoing Breast-Conserving Surgery for Ductal Carcinoma of the Breast

NCT00602628

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +14 more
Locations: Royal Marsden - Surrey Sutton, England, United Kingdom

View Trial Details

Completed

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

NCT00354640

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer

NCT00002967

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +11 more
Locations: Baptist Medical Center - Birmingham Birmingham, Alabama, United States

Huntsville Hospital System Huntsville, Alabama, United States

MBCCOP - University of South Alabama Mobile, Alabama, United States

CCOP - Greater Phoenix Phoenix, Arizona, United States

View all 108 locations

View Trial Details

Completed

Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors

NCT00019331

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +88 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

NCT00245024

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

NCT00304096

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +11 more
Locations: University of Virginia Cancer Center Charlottesville, Virginia, United States

View Trial Details

Completed

Anastrozole in Treating Postmenopausal Women With DCIS or Stage I-III Breast Cancer

NCT00244959

Conditions: Adenocarcinoma, Breast Cancer, Breast Carcinoma In Situ, +12 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Neoplasms, Ductal, Lobular, and Medullary

Neoplasms, Ductal, Lobular, and Medullary trial results

Related conditions